PeptiDream Inc. (4587.T) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	19.1B	18.5B	46.7B	28.7B	26.9B
Cost of Revenue	2.7B	11.0B	12.2B	11.5B	8.7B
Gross Profit	2.0B	7.5B	34.5B	17.2B	18.1B
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	1.9B	7.5B	9.1B	7.3B	6.2B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	8.1M	61.9M	278.6M	39.2M	11.1M
Total Operating Expenses	1.9B	7.5B	9.4B	7.3B	6.2B
Cost and Expenses	23.8B	23.5B	25.6B	21.9B	17.9B
Operating Income (EBIT)	(4.8B)	(5.0B)	21.1B	6.8B	9.0B
Non-Operating
Interest Income	94.8M	242.6M	411.2M	191.0M	189.0M
Interest Expense	155.0M	500.3M	658.9M	2.3B	2.3B
Net Interest Income	(60.2M)	(257.7M)	(247.7M)	(2.1B)	(2.1B)
Other Non-Op Income/Expense	656.0K	23.2M	1.0M	5.1M	13.5M
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	(1.2B)	(5.3B)	20.9B	4.4B	6.7B
Income Tax Expense	(347.2M)	(1.6B)	5.9B	1.3B	(901.0M)
Bottom Line
Net Income	(3.6B)	(3.7B)	15.0B	3.0B	7.6B
Earnings from Cont. Ops	—	—	—	—	—
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(3.6B)	(3.7B)	15.0B	3.0B	7.6B
Per Share
Basic EPS	(¥28)	(¥29)	¥116	¥23	¥58
Diluted EPS	(¥28)	(¥29)	¥116	¥23	¥58
Revenue Per Share	¥147	¥143	¥360	¥221	¥207
Shares
Basic Shares Outstanding	129.2M	129.3M	129.6M	129.7M	129.8M
Diluted Shares Outstanding	—	—	—	—	—
Profitability Metrics
EBITDA	(597.5M)	(2.9B)	23.4B	9.2B	11.0B
D&A	542.5M	2.1B	2.2B	2.4B	2.0B
EBIT	(4.8B)	(5.0B)	21.1B	6.8B	9.0B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026